ANTONUCCI, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 562
EU - Europa 206
AS - Asia 91
AF - Africa 7
Totale 866
Nazione #
US - Stati Uniti d'America 560
IT - Italia 82
IE - Irlanda 53
CN - Cina 49
SE - Svezia 36
VN - Vietnam 18
FI - Finlandia 7
KR - Corea 7
HK - Hong Kong 6
NG - Nigeria 6
UA - Ucraina 6
IN - India 4
NL - Olanda 4
ES - Italia 3
AT - Austria 2
DE - Germania 2
FR - Francia 2
RO - Romania 2
SG - Singapore 2
TH - Thailandia 2
BY - Bielorussia 1
CA - Canada 1
GB - Regno Unito 1
GE - Georgia 1
HN - Honduras 1
JP - Giappone 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
PL - Polonia 1
RS - Serbia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 866
Città #
Chandler 151
Dublin 53
Nyköping 33
Fairfield 28
Torino 20
Ashburn 19
Medford 16
Princeton 16
Turin 15
Hangzhou 14
Wilmington 9
Beijing 8
Hebei 8
Houston 8
New York 8
Cambridge 7
Seattle 7
Seoul 7
Washington 7
Woodbridge 7
Abuja 6
Lappeenranta 6
Boston 5
Ann Arbor 4
Chengdu 4
Dong Ket 4
Fremont 4
Bologna 3
Guiyang 3
Hong Kong 3
Jacksonville 3
Los Angeles 3
Milan 3
Norwalk 3
Pune 3
San Diego 3
Upper Marlboro 3
Bassano del Grappa 2
Chicago 2
Chongqing 2
Falls Church 2
Guangzhou 2
Mele 2
Noceto 2
Padova 2
Pontevedra 2
Saluzzo 2
San Mateo 2
Vienna 2
Amsterdam 1
Baricella 1
Belgrade 1
Berlin 1
Bucharest 1
Cape Town 1
Casalnuovo Di Napoli 1
Changsha 1
Collegno 1
Falconara Marittima 1
Florence 1
Garden City 1
Genoa 1
Glenwood 1
Helsinki 1
Iernut 1
London 1
Madrid 1
Modena 1
Montréal 1
Mumbai 1
Nanjing 1
Pian Camuno 1
Piemonte 1
Rende 1
Rome 1
Senago 1
Shanghai 1
Silver Spring 1
Singapore 1
Stockholm 1
Tegucigalpa 1
Tokyo 1
Vaduz 1
Warsaw 1
Totale 563
Nome #
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV 81
Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients 62
Analytical validation and clinical application of rapid serological tests for sars-cov-2 suitable for large-scale screening 59
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants 57
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma 55
Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection? 52
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients 46
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy 45
Validation and Clinical Application of a New Liquid Chromatography Coupled to Mass Spectrometry (HPLC-MS) Method for Dalbavancin Quantification in Human Plasma 44
Long-Term Pharmacokinetics of Dalbavancin in ABSSSI and Osteoarticular Settings: A Real-Life Outpatient Context 43
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz 43
Vitamin d-related genetics as predictive biomarker of clinical remission in adalimumab-treated patients affected by crohn’s disease: A pilot study 43
Seasonal variation of antiretroviral drug exposure during the year: The experience of 10 years of therapeutic drug monitoring 42
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? 40
Longitudinal analysis of antibody response following SARS-CoV-2 infection in pregnancy: From the first trimester to delivery 38
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease 37
Pregnancy and COVID-19: The Possible Contribution of Vitamin D 27
COVID-19: A Possible Contribution of the MAPK Pathway 15
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants 15
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics 13
A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis 13
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis 13
Gender differences in five different drug pharmacokinetics 8
Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality 7
Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study 4
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease 3
Totale 905
Categoria #
all - tutte 4.646
article - articoli 0
book - libri 0
conference - conferenze 85
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 3 5 10 9 4 4 12 12 42
2021/2022217 11 1 14 8 31 16 9 4 6 11 63 43
2022/2023403 34 37 11 28 31 88 18 35 61 13 28 19
2023/2024184 20 40 22 16 11 26 8 6 13 19 3 0
Totale 905